A Win For VIVUS, Inc.

Wed 05 Feb 20 at 05:30 PM
A Win For VIVUS, Inc.

VIVUS, Inc. (VVUS:NASDAQ) jumped higher at $3.38, a gain of 47%. The stock appeared on our News Catalysts scanner on Wed 05 Feb 20 at 08:09 AM in the 'RECOMMENDATION' category. From Tue 14 Jan 20, the stock recorded 42.86% Up Days and 40.00% Green Days

The share price of the company has been moving sideways in recent weeks.

About VIVUS, Inc. (VVUS:NASDAQ)

VIVUS Incis a biopharmaceutical company engaged in the development and commercialization of therapeutic products for large underserved markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile dysfunction.

Share